ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 86 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,094,000 | -73.4% | 100,665 | -58.2% | 0.11% | -73.3% |
| Q3 2016 | $7,887,000 | -48.8% | 240,665 | -61.0% | 0.42% | -50.8% |
| Q2 2016 | $15,403,000 | +624.2% | 616,865 | +610.1% | 0.85% | +491.6% |
| Q1 2016 | $2,127,000 | -83.5% | 86,865 | -77.7% | 0.14% | -69.1% |
| Q4 2015 | $12,872,000 | +0.8% | 389,700 | 0.0% | 0.46% | +0.7% |
| Q3 2015 | $12,767,000 | -43.3% | 389,700 | -8.3% | 0.46% | -30.6% |
| Q2 2015 | $22,512,000 | +1318.5% | 425,000 | +672.7% | 0.66% | +1441.9% |
| Q1 2015 | $1,587,000 | +4.3% | 55,000 | -54.2% | 0.04% | +7.5% |
| Q3 2014 | $1,522,000 | -24.2% | 120,000 | +20.0% | 0.04% | -33.3% |
| Q2 2014 | $2,007,000 | – | 100,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |